Rank: 70
2016 Rank79
R&D Spend:$32,254,000
Fiscal year ending:12-31-16
Click here to see all 100

Conmed is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. With products that are recognized as technological leaders by the specialties they serve, caregivers within the orthopedic, sports medicine, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology markets.

Conmed completes acquisition of surgiquest, inc. Conmed announces definitive agreement to acquire surgiquest, inc. Conmed corporation issues a voluntary device correction for padpro and r2 multi-function defibrillation electrodes.

Big 100 Mini Logo Key Personnel: Curt Hartman, CEO; Patrick Beyer, president, int'l; Terence Bergé, VP, corporate controller; Heather Cohen, EVP, HR & secretary; Nathan Folkert, VP & GM, U.S. orthopedics; Daniel Jonas, EVP, legal affairs & GC; John Kennedy, VP & GM, CET; Johonna Pelletier, VP & treasurer, tax; Stanley Peters, VP & GM, advanced surgical; Luke Pomilio, CFO & EVP, finance; Wilfredo Ruiz-Caban, EVP, regulatory affairs, quality assurance & operations; Peter Shagory, EVP, strategy & corporate development.;

525 French Road
Utica, New York